• OPEN AN ACCOUNT
Indian Indices
Nifty
24,666.90 88.55
(0.36%)
Sensex
81,330.56 182.34
( 0.22%)
Bank Nifty
54,801.30 -139.55
( -0.25%)
Nifty IT
37,853.55 498.95
( 1.34%)
Global Indices
Nasdaq
42,160.14 -270.96
(-0.64%)
Dow Jones
5,907.19 42.00
(0.72%)
Hang Seng
38,121.59 -61.67
(-0.16%)
Nikkei 225
8,602.92 -2.06
(-0.02%)
Forex
USD-INR
84.87 -0.55
(-0.64%)
EUR-INR
94.53 -1.49
(-1.55%)
GBP-INR
112.13 -1.43
(-1.26%)
JPY-INR
0.58 -0.01
(-2.04%)

EQUITY - MARKET SCREENER

Apollo Hospitals Enterprise Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
508869
INE437A01024
569.6290897
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
APOLLOHOSP
82.8
99510.49
EPS(TTM)
Face Value()
Div & Yield %
83.58
5
0.23
 

annvrridhhi ventures ltd
Jubilant Pharmova arm gets EIR from USFDA for Maryland facility
Mar 13,2025
The US Food and Drug Administration (USFDA) had classified the inspection as voluntary action indicated (VAI) and confirmed that the inspection is now closed. The inspection took place in January 2025.

As per the company’s previous disclosure on 18 April 2024, the facility is not expected to manufacture any products as it has closed manufacturing operations.

Jubilant Pharmova is engaged in radiopharma, allergy immunotherapy, CDMO of sterile injectable, generics, contract research development and manufacturing (CRDMO) and proprietary novel drugs businesses.

The company's consolidated net profit jumped 51% to Rs 100.90 crore during the quarter as compared with Rs 66.80 crore in Q3 FY24. Net sales increased 8.9% YoY to Rs 1,813.70 crore in Q3 FY25.

The scrip rose 0.32% to Rs 868 on the BSE.